Our medical weight loss program is a comprehensive, medically-supervised approach combining prescription medications, lifestyle counseling, and ongoing medical support to help you achieve sustainable weight loss results.

Patients typically qualify with a BMI of 30 or higher, or 27 or higher with weight-related health conditions such as diabetes, high blood pressure, or joint pain. During your consultation, we’ll review your medical history to determine the best approach for your individual needs.

Most patients begin seeing results within the first few weeks of starting their program. However, results vary based on individual factors including genetics, age, starting weight, and adherence to the treatment plan. We focus on achieving sustainable, lasting results rather than quick fixes.

Yes, our medically supervised approach is specifically designed to be safe for patients with various health conditions. Christel Backert’s medical training enables her to work with patients who have diabetes, high blood pressure, and other conditions, adjusting treatments as needed for optimal safety and effectiveness.

Our program follows American Board of Obesity Medicine standards and is supervised by Christel Backert, NP-c, combining FDA-approved medications with personalized lifestyle changes. Unlike commercial diet programs, we provide ongoing medical support, safety monitoring, and treatment plans based on your individual health profile and genetics.

We do not accept insurance for our services at this time. However, many of our patients successfully use Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) to cover costs. We’re also happy to provide detailed receipts you may submit to your insurance provider for potential out-of-network reimbursement.

Yes, our medically supervised approach is specifically designed to be safe for patients with various health conditions. Christel Backert’s medical training enables her to work with patients who have diabetes, high blood pressure, and other conditions, adjusting treatments as needed for optimal safety and effectiveness.

We provide access to FDA-approved prescription weight loss medications including GLP-1 receptor agonists (semaglutide, Wegovy, Zepbound), Contrave, and other evidence-based treatments as appropriate for each patient’s medical profile.

Yes, both brand name and FDA-approved generic versions may be available depending on supply, and individual patient needs. Our team will discuss the best options for your specific situation.

Clinical trials demonstrate that GLP-1 medications are safe for long-term use under proper medical supervision. Your healthcare provider will monitor your kidney function, blood glucose levels, and overall health regularly to ensure safety. Any concerns about thyroid cancer risk or other rare side effects are carefully evaluated during your initial assessment.

Weight regain is common when GLP-1 medications are discontinued without proper transition planning. MEDY Weight Loss develops comprehensive maintenance strategies including gradual medication tapering, continued nutritional support, and behavioral modifications to help maintain your results. Some patients may benefit from ongoing lower-dose maintenance therapy.

Yes, GLP-1 medications were originally developed for diabetes management and remain highly effective for this purpose. Many patients with type 2 diabetes experience both improved blood glucose control and significant weight loss. Your provider will adjust your other diabetes medications accordingly to prevent hypoglycemia.

Weight loss sustainability depends on continued healthy habits and lifestyle modifications. While GLP-1 medications are highly effective during treatment, long-term success requires ongoing commitment to nutrition, exercise, and behavioral changes. MEDY Weight Loss provides transition support and long-term maintenance planning to maximize your chances of keeping weight off permanently.

FDA approval covers up to 12 weeks of continuous use. Some patients may restart treatment after breaks under careful medical supervision, but longer-term use requires alternative medications. Our healthcare provider will assess your individual situation and determine the most appropriate treatment duration for your specific needs.

Possible with careful monitoring and well-controlled conditions. Our healthcare provider evaluates each case individually and may require additional precautions or more frequent follow-ups. Patients with diabetes require careful monitoring as phentermine can affect blood sugar levels. Blood pressure must be stable and controlled before starting treatment.

We provide gradual transition support with continued lifestyle counseling to maintain weight loss achievements. Some appetite return is normal, but established habits help prevent significant weight regain. Our team works with you to develop a sustainable maintenance plan that includes nutrition guidance and exercise routines.

Nausea, constipation, headache, and dry mouth are most frequent, typically improving after the first few weeks. Most patients tolerate these effects well with proper dose titration.

Clinical studies show average 5-10% body weight reduction over 6-12 months when combined with a healthy diet and exercise. Individual results vary based on starting weight and adherence to lifestyle changes.